Toward regulatory acceptance and improving the prediction confidence of in silico approaches: a case study of genotoxicity

被引:9
作者
Tcheremenskaia, Olga [1 ]
Benigni, Romualdo [2 ]
机构
[1] Ist Super Sanita ISS, Environm & Hlth Dept, Rome, Italy
[2] Alpha Pretox, Rome, Italy
关键词
Genotoxicity; in silico; (Q)SAR; read-across; AOP; IATA; uncertainties; mutagenicity; weight-of-evidence; regulatory framework; ADVERSE OUTCOME PATHWAY; EXPERT KNOWLEDGE; SALMONELLA MUTAGENICITY; QSAR MODEL; IDENTIFICATION; CHEMICALS; SYSTEMS; CARCINOGENICITY; PERSPECTIVES; MANAGEMENT;
D O I
10.1080/17425255.2021.1938540
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Genotoxicity is an imperative component of the human health safety assessment of chemicals. Its secure forecast is of the utmost importance for all health prevention strategies and regulations. Areas covered: We surveyed several types of alternative, animal-free approaches ((quantitative) structure-activity relationship (Q)SAR, read-across, Adverse Outcome Pathway, Integrated Approaches to Testing and Assessment) for genotoxicity prediction within the needs of regulatory frameworks, putting special emphasis on data quality and uncertainties issues. Expert opinion: (Q)SAR models and read-across approaches for in vitro bacterial mutagenicity have sufficient reliability for use in prioritization processes, and as support in regulatory decisions in combination with other types of evidence. (Q)SARs and read-across methodologies for other genotoxicity endpoints need further improvements and should be applied with caution. It appears that there is still large room for improvement of genotoxicity prediction methods. Availability of well-curated high-quality databases, covering a broader chemical space, is one of the most important needs. Integration of in silico predictions with expert knowledge, weight-of-evidence-based assessment, and mechanistic understanding of genotoxicity pathways are other key points to be addressed for the generation of more accurate and trustable results.
引用
收藏
页码:987 / 1005
页数:19
相关论文
共 97 条
[51]  
Ives C., 2017, APPL IN VITRO TOXICO, V3, P298
[52]   An evaluation of in-house and off-the-shelf in silico models: Implications on guidance for mutagenicity assessment [J].
Jolly, Robert ;
Ahmed, Kausar Begam Riaz ;
Zwickl, Craig ;
Watson, Ian ;
Gombar, Vijay .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 71 (03) :388-397
[53]  
JRC, 2010, EFSA Supporting Publications, V7, DOI [DOI 10.2903/SP.EFSA.2010.EN-50, 10.2903/sp.efsa.2010.EN-50]
[54]   Towards the creation of an international toxicology information centre [J].
Judson, PN ;
Cooke, PA ;
Doerrer, NG ;
Greene, N ;
Hanzlik, RP ;
Hardy, C ;
Hartmann, A ;
Hinchliffe, D ;
Holder, J ;
Müller, L ;
Steger-Hartmann, T ;
Rothfuss, A ;
Smith, M ;
Thomas, K ;
Vessey, JD ;
Zeiger, E .
TOXICOLOGY, 2005, 213 (1-2) :117-128
[55]   Derivation and validation of toxicophores for mutagenicity prediction [J].
Kazius, J ;
McGuire, R ;
Bursi, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) :312-320
[56]   The implementation of RAAF in the OECD QSAR Toolbox [J].
Kuseva, Chanita ;
Schultz, Terry W. ;
Yordanova, Darina ;
Tankova, Ksenia ;
Kutsarova, Stela ;
Pavlov, Todor ;
Chapkanov, Atanas ;
Georgiev, Marin ;
Gissi, Andrea ;
Sobanski, Tomasz ;
Mekenyan, Ovanes G. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, 105 :51-61
[57]  
Madden JC, 2013, ISSUES TOXICOL, V17, P72, DOI 10.1039/9781849734400-00072
[58]  
Marchetti, 2016, ADVERSE OUTCOME PATH, DOI [10.1787/5jlsvvxn1zjc-en, DOI 10.1787/5JLSVVXN1ZJC-EN]
[59]   The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring [J].
Marchetti, Francesco ;
Massarotti, Alberto ;
Yauk, Carole L. ;
Pacchierotti, Francesca ;
Russo, Antonella .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2016, 57 (02) :87-113
[60]   In silico prediction of chromosome damage: comparison of three (Q)SAR models [J].
Morita, Takeshi ;
Shigeta, Yoshiyuki ;
Kawamura, Tomoko ;
Fujita, Yurika ;
Honda, Hiroshi ;
Honma, Masamitsu .
MUTAGENESIS, 2019, 34 (01) :91-100